Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Becton Dickinson (NY: BDX )

251.79 +3.68 (+1.48%)
Official Closing Price Updated: 7:00 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,738,793
Open 249.49
Bid (Size) 248.36 (1)
Ask (Size) 254.94 (1)
Prev. Close 248.11
Today's Range 249.30 - 253.50
52wk Range 215.90 - 269.06
Shares Outstanding 287,190,180
Dividend Yield 1.32%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
The Latest Analyst Ratings for Becton, Dickinson
 
Via Benzinga
Intuitive Surgical Gives Buying Opportunity Off Its 52 Week Highs
Intuitive Surgical (NASDAQ: ISRG) manufactures the revolutionary da Vinci Surgical System, the leader in robotic-assisted surgery systems. Da Vinci is turning 
Via MarketBeat
Exposures COVID-19 Product Safety

Performance

YTD
-1.71%
-1.71%
1 Month
-0.27%
-0.27%
3 Month
+6.59%
+6.59%
6 Month
+2.27%
+2.27%
1 Year
-0.22%
-0.22%

More News

Read More
Here's How Much You Would Have Made Owning Becton, Dickinson Stock In The Last 20 Years
Via Benzinga
Best Robotic Stocks For 2023
Via Talk Markets
BD Scores FDA Clearance For Artificial Intelligence Software To Interpret Bacterial Growth
Via Benzinga
Becton, Dickinson's Return On Capital Employed Overview
Via Benzinga
$1000 Invested In This Stock 20 Years Ago Would Be Worth $6,900 Today
Via Benzinga
Where Becton, Dickinson Stands With Analysts
Via Benzinga
Here's How Much $100 Invested In Becton, Dickinson 10 Years Ago Would Be Worth Today
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 5, 2023
Via Benzinga
Becton, Dickinson Shares Dip Despite Q2 Earnings Beat - Here's The Deatils
Via Benzinga
Becton Dickinson 'Capable Of Sustaining A Breakout', Analyst Upgrades Stock With 20% Upside Potential
Via Benzinga
Dividend Income Update March 2023
Via Talk Markets
The Latest Analyst Ratings for Becton, Dickinson
Via Benzinga
Becton, Dickinson's Debt Overview
Via Benzinga
(BDX) - Analyzing Becton, Dickinson's Short Interest
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2023
Via Benzinga
7 Dividend Aristocrats to Buy for Consistent Income Growth
Via InvestorPlace
3 Healthcare Spinoffs Worth a Look, But 1 Has the Best Long-Term Potential
Via The Motley Fool
Healthcare Stocks With at Least 30 Years of Dividend Increases
Via MarketBeat
3 Stocks To Buy For Consistent Dividend Growth
Via Talk Markets
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
Via TheNewswire.com
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
Via News Direct
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
Via Benzinga
Lucira Stock Jumps over 250% on FDA Approval, Beware Chapter 11
Via MarketBeat
Topics Initial Public Offering
Exposures COVID-19 Product Safety Securities Market
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.